EBMT-EHA CAR-T 2019 | CAR-T: symptoms and their assessment

Rose Ellard

In this video, Rose Ellard, MSc, Kings College Hospital NHS Foundation Trust, London, UK, gives an overview of adverse effects which can result from CAR-T, including cytokine release syndrome (CRS) and neurotoxicity. She goes on to discuss a novel immune effector cell-associated neurotoxicity syndrome (ICANS) patient assessment tool. This video was recorded at the 1st European CAR T-Cell Meeting, held in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).

Share this video